These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 1384900

  • 21. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
    Choi D, Perrin M, Hoffmann S, Chang AE, Ratanatharathorn V, Uberti J, McDonagh KT, Mulé JJ.
    Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
    [Abstract] [Full Text] [Related]

  • 22. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
    Rumi C, Rutella S, Teofili L, Etuk B, Ortu La Barbera E, Micciulli G, Voso MT, Leone G.
    Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ, Zimmerman T, Meyers S, Bender JG, Williams SF.
    Prog Clin Biol Res; 1994 Mar; 389():421-7. PubMed ID: 7535451
    [No Abstract] [Full Text] [Related]

  • 25. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
    Herrmann RP, O'Reilly J, Meyer BF, Lazzaro G.
    Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
    [Abstract] [Full Text] [Related]

  • 26. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 27. Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with use during steady-state hematopoiesis.
    Möhle R, Pförsich M, Fruehauf S, Witt B, Krämer A, Haas R.
    Bone Marrow Transplant; 1994 Nov; 14(5):827-32. PubMed ID: 7534163
    [Abstract] [Full Text] [Related]

  • 28. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T, Muroi K, Tomizuka H, Amemiya Y, Miura Y.
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [Abstract] [Full Text] [Related]

  • 29. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S, Law P, Young D, Ho AD.
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [Abstract] [Full Text] [Related]

  • 30. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
    Tong J, Gianni AM, Siena S, Srour EF, Bregni M, Hoffman R.
    Blood Cells; 1994 Nov; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
    [Abstract] [Full Text] [Related]

  • 31. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 32. The absolute number of circulating CD34+ cells predicts the number of hematopoietic stem cells that can be collected by apheresis.
    Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y, Steenssens L, van Camp B, De Waele M.
    Bone Marrow Transplant; 1996 Apr; 17(4):509-15. PubMed ID: 8722347
    [Abstract] [Full Text] [Related]

  • 33. Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
    Sutherland DR, Yeo EL, Stewart AK, Nayar R, DiGiusto R, Zanjani E, Hoffman R, Murray LJ.
    Exp Hematol; 1996 Jun; 24(7):795-806. PubMed ID: 8647230
    [Abstract] [Full Text] [Related]

  • 34. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [Abstract] [Full Text] [Related]

  • 35. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors.
    Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Gregg A, Pillow A, Bolton A.
    Bone Marrow Transplant; 1992 Jan; 9(1):11-7. PubMed ID: 1347478
    [Abstract] [Full Text] [Related]

  • 36. Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection.
    Inaba T, Shimazaki C, Hirata T, Ashihara E, Okawa K, Oku N, Goto H, Fujita N, Tsuji H, Nakagawa M.
    Bone Marrow Transplant; 1994 May; 13(5):527-32. PubMed ID: 7519935
    [Abstract] [Full Text] [Related]

  • 37. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 38. A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.
    Kwekkeboom J, Buurman DE, Ploemacher RE, Baars JW, Loos HA, Slaper-Cortenbach IC.
    Exp Hematol; 1998 May; 26(5):400-8. PubMed ID: 9590656
    [Abstract] [Full Text] [Related]

  • 39. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC, Millar JL, Shepherd V, Blackwell P, Porter H, Cunningham D, Judson I, Treleaven J, Powles RL, Catovsky D.
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [Abstract] [Full Text] [Related]

  • 40. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
    Kiss JE, Rybka WB, Winkelstein A, deMagalhaes-Silverman M, Lister J, D'Andrea P, Ball ED.
    Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.